Literature DB >> 18937570

Nosocomial infection after septic shock among intensive care unit patients.

Caroline Landelle1, Alain Lepape, Adrien Français, Eve Tognet, Hélène Thizy, Nicolas Voirin, Jean François Timsit, Guillaume Monneret, Philippe Vanhems.   

Abstract

OBJECTIVES: To measure the incidence of nosocomial infection (NI) among patients with septic shock according to the place of septic shock acquisition and to evaluate the increase in the risk of pulmonary infection associated with septic shock.
DESIGN: Prospective cohort study.
SETTING: Two intensive care units (ICUs) of a French university hospital. PATIENTS AND METHODS: The study included a total of 209 septic shock patients during the period December 1, 2001 through April 30, 2005. The place of septic shock acquisition for 108 patients was the community; for 87, the hospital; and for 14, the ICU. To evaluate the impact of septic shock on the development of pulmonary infection, a competitive and adjusted hazard ratio (aHR) model was applied to nontrauma ICU patients.
RESULTS: Among the 209 study patients, 48 (23%) experienced 66 NIs after septic shock. There was no significant difference in the NI attack rates according to place of acquisition: for the community acquisition group, 24 cases per 100 patients (95% confidence interval [CI], 16-32); for the hospital acquisition group, 20 cases per 100 patients (95% CI, 11-28); and for the ICU acquisition group, 36 cases per 100 patients (95% CI, 11-61) (P = .3). For nontrauma ICU patients, the presence of community-acquired septic shock was found to be independently associated with a higher incidence of pulmonary infection, compared with the absence of septic shock (aHR, 2.12 [95% CI, 1.08-4.16]; P = .03).
CONCLUSIONS: The risk of NI did not differ by the place of septic shock acquisition. The risk of pulmonary infection was higher for ICU patients with community-acquired septic shock who were admitted for underlying nontrauma disease. Studies are needed to investigate the pathogenic mechanisms that facilitate pulmonary infection in this population, taking into account exposure to invasive devices and immunosuppression after the initial phase of septic shock.

Entities:  

Mesh:

Year:  2008        PMID: 18937570     DOI: 10.1086/591859

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  14 in total

1.  Very low birth weight neonates who survive early-onset sepsis do not have an increased risk of developing late-onset sepsis.

Authors:  Cheryl B Lin; Christoph P Hornik; Reese Clark; C Michael Cotten; Daniel K Benjamin; Michael Cohen-Wolkoweiz; P Brian Smith; James L Wynn
Journal:  Early Hum Dev       Date:  2012-07-27       Impact factor: 2.079

Review 2.  Advances in the understanding and treatment of sepsis-induced immunosuppression.

Authors:  Fabienne Venet; Guillaume Monneret
Journal:  Nat Rev Nephrol       Date:  2017-12-11       Impact factor: 28.314

3.  Increased MerTK expression in circulating innate immune cells of patients with septic shock.

Authors:  Caroline Guignant; Fabienne Venet; Séverine Planel; Julie Demaret; Aurélie Gouel-Chéron; Christophe Nougier; Arnaud Friggeri; Bernard Allaouchiche; Alain Lepape; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2013-07-09       Impact factor: 17.440

4.  Model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsis.

Authors:  Gabriela Barrera; Verónica Landoni; Daiana Martire-Greco; Paula Chiarella; Roberto Meiss; Sonia A Gómez; Fernanda Alves-Rosa; Barbara Rearte; Martín Isturiz; Marina S Palermo; Gabriela C Fernández
Journal:  Infect Immun       Date:  2010-12-20       Impact factor: 3.441

5.  Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock.

Authors:  Caroline Landelle; Alain Lepape; Nicolas Voirin; Eve Tognet; Fabienne Venet; Julien Bohé; Philippe Vanhems; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2010-07-23       Impact factor: 17.440

6.  High-mobility group box-1 protein serum levels do not reflect monocytic function in patients with sepsis-induced immunosuppression.

Authors:  Nadine Unterwalder; Christian Meisel; Konstantinos Savvatis; Ben Hammoud; Christina Fotopoulou; Hans-Dieter Volk; Petra Reinke; Joerg C Schefold
Journal:  Mediators Inflamm       Date:  2010-06-21       Impact factor: 4.711

Review 7.  Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies.

Authors:  Fabienne Venet; Anne-Claire Lukaszewicz; Didier Payen; Richard Hotchkiss; Guillaume Monneret
Journal:  Curr Opin Immunol       Date:  2013-05-28       Impact factor: 7.486

8.  Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.

Authors:  Caroline Guignant; Alain Lepape; Xin Huang; Hakim Kherouf; Laure Denis; Françoise Poitevin; Christophe Malcus; Aurélie Chéron; Bernard Allaouchiche; François Gueyffier; Alfred Ayala; Guillaume Monneret; Fabienne Venet
Journal:  Crit Care       Date:  2011-03-21       Impact factor: 9.097

Review 9.  Alterations of dendritic cells in sepsis: featured role in immunoparalysis.

Authors:  Xia Fan; Zheng Liu; He Jin; Jun Yan; Hua-ping Liang
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

10.  CCR4 Controls the Suppressive Effects of Regulatory T Cells on Early and Late Events during Severe Sepsis.

Authors:  Raphael Molinaro; Cyntia Pecli; Rafael F Guilherme; José Carlos Alves-Filho; Fernando Q Cunha; Claudio Canetti; Steven L Kunkel; Marcelo T Bozza; Claudia F Benjamim
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.